Becky Inkster

From Brede Wiki
Jump to: navigation, search
Researcher (help)
Becky Inkster
Affiliation: Department of Psychiatry, University of Cambridge
Institute of Psychiatry
Location: United Kingdom
Position:
Interest(s): Neuroimaging genetics
Epigenetics
Databases: Microsoft Academic Search
Link(s): https://sites.google.com/site/beckyinkster/
https://iris.ucl.ac.uk/research/personal?upi=BINKS13
Search: PubMed (first author) PubMed
Google Scholar
Scopus
English Wikipedia
Twitter
DuckDuckGo

Becky Inkster is the Project Manager of the Neuroscience in Psychiatry Network (NSPN) Wellcome Trust Strategic Award and is based in the Department of Psychiatry at University of Cambridge, United Kingdom. Her academic interests include neuroimaging genetics and epigenetics.

Inkster has a DPhil degree from Oxford University and has previous affiliations with GlaxoSmithKline Clinical Imaging Centre, Imperial College London (ICL), and the Institute of Psychiatry, King's College London. She currently holds an honorary contract at University College London.

[edit] Work

  1. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder
  2. Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease
  3. Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder
  4. Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression
  5. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms

[edit] As co-author

  1. Thomas E. Nichols, Becky Inkster(2009). "Comparison of whole brain multiloci association methods". [1]
  2. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study
  3. Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration
  4. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration
  5. Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls
Personal tools